These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1318685

  • 21. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.
    Cochereau-Massin I, Bauchet J, Marrakchi-Benjaafar S, Saleh-Mghir A, Faurisson F, Vallois JM, Vallee E, Pocidalo JJ.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):633-6. PubMed ID: 8388193
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.
    Nakata K, Maeda H, Fujii A, Arakawa S, Umezu K, Kamidono S.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):188-90. PubMed ID: 1317145
    [Abstract] [Full Text] [Related]

  • 27. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA, Miller B, Schwartz R, Henry DC, Nolan T, McCabe A, Magner DJ, Talbot GH.
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [Abstract] [Full Text] [Related]

  • 28. Methicillin-resistant Staphylococcus aureus caruncle abscess.
    Koo L, Chang EL.
    Ophthalmic Plast Reconstr Surg; 2007 Apr; 23(2):160-1. PubMed ID: 17413640
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2312-7. PubMed ID: 2128441
    [Abstract] [Full Text] [Related]

  • 33. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC, Chang SC, Hsu LY, Hsieh WC, Luh KT.
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.
    Crokaert F, Aoun M, Duchateau V, Grenier P, Vandermies A, Klastersky J.
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):696-8. PubMed ID: 8894585
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F, Martín MM, Izquierdo J, Gomez-Lus ML, Prieto J.
    Chemotherapy; 1996 Aug; 42(5):354-62. PubMed ID: 8874975
    [Abstract] [Full Text] [Related]

  • 40. In vitro activities of five quinolones against Chlamydia pneumoniae.
    Hammerschlag MR, Hyman CL, Roblin PM.
    Antimicrob Agents Chemother; 1992 Mar; 36(3):682-3. PubMed ID: 1320366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.